홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KYMR
#1075
Kymera Therapeutics, Inc. Common Stock
89.891
0
USD
+1.54%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.54%
월간 변동
+11.71%
6달 변화
+52.10%
년간 변동율
+52.10%
이전 종가
88.530
0
Open
89.865
0
Bid
Ask
Low
89.865
0
High
89.891
0
양
78
마켓
주식
헬스케어
KYMR
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
44.81 M
51.7 M
55.18 M
61.11 M
64.94 M
81.64 M
—
Valuation ratios
Enterprise value
2.75 B
3.23 B
1.3 B
1.44 B
2.49 B
6 B
14.43 B
Price to earnings ratio
—
—
-8.66
-10.06
-13.5
-21.09
-58.15
Price to sales ratio
—
—
28.61
18.83
64.14
167.66
383.27
Price to cash flow ratio
—
—
-8.75
-14.39
-15.52
-28.23
-70.51
Price to book ratio
—
—
2.73
3.75
3.61
4.16
7.08
EBITDA 비율에 대한 기업 가치
-61.68
-32.96
-8.23
-8.89
-8.27
-15.77
-40.26
Profitability ratios
Return on assets %
-0.09
-0.17
-0.26
-0.26
-0.23
-0.18
-0.26
Return on equity %
-0.16
-0.22
-0.32
-0.37
-0.27
-0.2
-0.3
Return on invested capital %
-65.97
-160.54
-290.93
—
—
-199.2
—
Gross margin %
100
100
100
100
0
0
0
Operating margin %
-136.05
-138.03
-344.37
-210.62
-555.82
-891.07
-7 830.73
EBITDA margin %
-130.87
-134.74
-338.02
-206.08
-640.16
-969.87
-8 054.78
Net margin %
-133.96
-137.6
-330.6
-186.99
-475.57
-794.04
-6 967.04
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.73
4.88
5.88
4.73
7.53
10.47
34.66
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.13
0.08
0.13
0.06
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.84
-1.76
-2.59
-2.76
-2.83
EBIT per share
—
—
-2.99
-2.84
-4.11
-4.6
-4.68
EBITDA per share
—
—
-2.93
-2.78
-4.02
-4.5
-4.58
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.55
6.42
6.51
10.04
29.88
Net current asset value per share
—
—
7.78
6.94
6.8
10.31
31.67
Tangible book value per share
—
—
9.09
6.77
11.14
18.7
51.42
Working capital per share
—
—
6.45
5.48
5.9
9.33
28.04
Book value per share
—
—
9.09
6.77
11.14
18.7
51.42
뉴스
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Kymera, 약물 개발 전략 인사이트 제시
Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development
Kymera, 아토피 피부염 임상 시험 데이터 AAD 학회서 발표
Kymera to present atopic dermatitis trial data at AAD meeting
Kymera at TD Cowen Conference: Strategic Insights on Drug Programs
Stephens raises Kymera Therapeutics price target to $100 on pipeline
Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway
모건 스탠리, 카이메라 테라퓨틱스 목표 주가 하향 조정
Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress